CD4 and chronic kidney disease: Similarly, no differences were observed in the CD3+ [HC: 46.25% (17.39) vs. CKD: 42.26% (29.55), p = 0.447), CD4+ (61.86% (12.55) vs. 60.99% (14.81), p = 0.645] or CD8+ subsets [33.86% (12.95) vs. 34.85% (12.00), p = 0.800].